Cost‐Effective Analysis of Screening for Biliary Atresia With the Stool Color Card
Authors:
- 1 January 2015
- journal article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 60 (1) , 91-98
Abstract
Background: Biliary atresia (BA) is the leading cause of pediatric end‐stage liver disease and liver transplantation in the United States. Early diagnosis leads to improved outcomes, but diagnosis is often delayed, leading to increased rates of transplantation and mortality.Methods: A Markov model was developed to simulate the natural history and transplant‐related outcomes of patients with BA in a US cohort studied for 20 years. Data regarding proportions of individuals in different health states, including transplant and death, were obtained from published literature. Costs were derived from the literature and the Johns Hopkins database of charges using the cost‐to‐charge ratio. Strategy A represented the status quo and assumed no screening. Strategy B used nationwide screening with the stool color card developed by the Taiwan Health Bureau. The cost associated with both strategies was compared with the number of life‐years gained, deaths, and the number of transplants for a 20‐year interval. A dominant strategy was one that was associated with lower cost alongside improved outcomes, including increases in life‐years gained, reductions in number of deaths, and reductions in number of transplants. One‐way and probabilistic sensitivity analyses were performed.Results: In strategy A, the 20‐year cost was $142,479,725 with 3702 life‐years, 74 deaths and 158 liver transplants. For strategy B, the cost was $133,893,563 with 3731.7 life‐years, 71 deaths and 147 liver transplants. There was a >97% probability that screening with the stool color card would be cost saving and associated with an increase in life‐years gained. Among all parameters, only stool color card specificity was associated with the potential for screening to no longer be cost saving.Conclusions: Compared with no screening, screening with the stool color card is a dominant strategy associated with lower costs and better outcomes. These findings suggest that screening with the stool color card could be an important, economically feasible strategy for improving outcomes in BA in the United States.Keywords
This publication has 42 references indexed in Scilit:
- Improving outcomes of biliary atresia: French national series 1986–2009Journal of Hepatology, 2013
- Elevated Bile Acids in Newborns with Biliary Atresia (BA)PLOS ONE, 2012
- Biliary Atresia in The Netherlands: Outcome of Patients Diagnosed between 1987 and 2008The Journal of Pediatrics, 2012
- Four hundred thirty consecutive pediatric living donor liver transplants: Variables associated with posttransplant patient and graft survivalLiver Transplantation, 2012
- Patients With Biliary Atresia Have Elevated Direct/Conjugated Bilirubin Levels Shortly After BirthPediatrics, 2011
- Health‐related quality of life in pediatric liver transplant recipients compared with other chronic disease groupsPediatric Transplantation, 2010
- Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in taiwanHepatology, 2010
- Liver Retransplantation in Children: A SPLIT Database Analysis of Outcome and Predictive Factors for SurvivalAmerican Journal of Transplantation, 2008
- Epidemiological features of biliary atresia in Taiwan, a national study 1996–2003Journal of Gastroenterology and Hepatology, 2007
- Predictors of Outcomes after Pediatric Liver Transplantation: An Analysis of More Than 800 Cases Performed at a Single InstitutionJournal of the American College of Surgeons, 2007